Abiopharma

🔍 AJB Investment Fund II, LP (Executive)

Company: JEWETT CAMERON TRADING CO LTD (JCTC)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 1,197 shares of JCTC at $2.9 per share (Direct)
  Date: 2026-08-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 468,444.00 | transaction_form_type: 4
• Acquired 5,000 shares of JCTC at $2.9 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 473,444.00 | transaction_form_type: 4
• Acquired 991 shares of JCTC at $2.9 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 474,435.00 | transaction_form_type: 4

Footnotes:

• REMARKS: (I) The transactions reported herein reflect open market purchases. The Reporting Persons undertake to provide full pricing information upon request. (2) Following the reported transactions, the aggregate beneficial ownership of the Reporting Persons consists of 474,435 shares, including: (a) 375,067 shares held by AJB Investment Fund II, LP; (b) 33,159 shares held individual retirement accounts for Adam J. Bradley; (c) 53,624 shares held in the individual retirement account for Melinda Bradley; (d) 12,585 shares held in accounts owned by the adult children of Adam J. Bradley and Melinda Bradley, over which Adam J. Bradley exercises investment discretion. (3) Adam J. Bradley may be deemed to beneficially own all 474,435 shares reported herein by virtue of his direct ownership, his control of AJB Capital, and his investment discretion over certain accounts, including those held by his adult children. (4) Melinda Bradley may be deemed to beneficially own 428,691 shares, consisting of (i) 375,067 shares held by AJB Investment Fund Il, LP, over which she shares voting and dispositive power as a managing member of AJB Capital, the fund's investment manager, and (ii) 53,624 shares held in her individual retirement account. Melinda Bradley does not exercise investment discretion over the 12,585 shares held in accounts owned by the adult children and therefore is not deemed to beneficially own such securities. ( 5) Each Reporting Person disclaims beneficial ownership of all securities reported herein except to the extent of such person's pecuniary interest therein.